STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. I, too, wanted to express how devastated I am over losing our colleague Helen Branswell. She was kind, scrupulous…
ImpactMinor 11/100
Why it mattersRule-based estimate: event keywords (+4), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published6 h ago (Thu, 15 Oct 2026 15:43:15 GMT)
RetrievedThu, 15 Oct 2026 19:01:34 GMT via rss
ClassifiedThu, 15 Oct 2026 19:01:36 GMT by heuristic
AuthorMeghana Keshavan